Page 4 - Indian Pharma

TMS Ep276: OPEC production cuts, Indian pharma exports, stocks, USB-C ports

How will OPEC production cuts affect India? Who is responsible for the quality of Indian pharma exports? Are consumption stocks a good bet now? What makes USB-C the best charging port? Answers here

Who is responsible for the quality of Indian pharma exports?

WHO has issued a global alert over four cough syrups made by an Indian pharma company, for alleged death of 66 children in The Gambia. Who are responsible for quality checks of Indian pharma exports?

Udaan to provide medicine delivery to pharmacies every 4-hour

As part of the new service offering, Udaan will provide medicine delivery to pharmacies every 4-hour with 4 delivery slot options in a day to order medicines across six cities

Indian pharma industry likely to grow to $130 bn by 2030, says IPA

The trade shows are jointly organised by Indian Pharma Machinery Manufacturers Association (IPMMA), Indian Analytical Instruments Association (IAIA) and Messe Muenchen

Inter-ministerial MoU inked for promotion of 'One Herb, One Standard'

A memorandum of understanding (MoU) was inked between the Pharmacopoeia Commission for Indian Medicine and Homoeopathy (Ministry of Ayush) and the Indian Pharmacopoeia Commission (Ministry of Health) here on Tuesday for inter-ministerial cooperation for the promotion and facilitation of "One Herb, One Standard". P K Prajapati, Director (in-charge) of the Pharmacopoeia Commission for Indian Medicine and Homoeopathy (PCIM&H), and Rajeev Singh Raghuvanshi, Secretary-cum-Scientific Director of the Indian Pharmacopoeia Commission (IPC), signed the MoU in the presence of Rajesh Kotecha, Secretary, Ministry of Ayush, according to a statement issued by the ministry. On the occasion, Kotecha said, "The primary objective of this MoU is the development of cooperative efforts between the PCIM&H and the IPC to promote public health by facilitating the development of harmonised herbal drug standards. Since both the PCIM&H and the IPC are working with the common cause, it is logical and .

Indian pharma industry may rebound to 8-11% growth rate, says Alkem

Alkem Laboratories expects the Indian pharmaceutical industry to rebound to 8-11 per cent growth rate with normalcy in activities as the pandemic eases out

Pharma SMEs stock up on a month's raw material amid supply disruptions

The lockdown in various Chinese provinces, including Shanghai, is likely to delay shipments by two weeks to a month, said domestic players.

Expand PLI scheme for pharma to make it research-linked, says industry

So far 55 drug manufacturers have been selected under the PLI scheme for pharma.

Govt removes export curbs on Remdesivir, active pharmaceutical ingredients

The Centre has also removed similar curbs for exports of organic LEDs (Light Emitting Diodes) and liquid crystals

US pricing pressure cloud over Indian pharma growth, say analysts

Complex pipeline, execution, and regulatory compliance hold key

Aurobindo Pharma net profit dips 22% to Rs 604 cr in December quarter

The Hyderabad-based drug maker had reported a consolidated net profit of Rs 777.3 crore in the same period of previous fiscal

Glenmark gets nod from US Food & Drug Administration for generic drug

Glenmark Pharmaceuticals on Friday said its US-based unit has received approval from the US health regulator to market Metronidazole Vaginal gel, in the American market. The drug firm has received final approval by the United States Food & Drug Administration (USFDA) for its product which is a generic version of Bausch Health US LLC's MetroGel-Vaginal, the drug firm said in a statement. According to IQVIA sales data for the 12-month period ending November 2021, the MetroGel-Vaginal Gel achieved annual sales of approximately around USD 60.4 million. Glenmark's current portfolio consists of 173 products authorised for distribution in the US marketplace and 46 ANDA's pending approval with the USFDA. In addition to these internal filings, the drug firm continues to identify and explore external development partnerships to supplement and accelerate the growth of its existing pipeline and portfolio, Glenmark noted.

Hyderabad's Biophore to manufacture ingredients of Pfizer's Covid drug

Biophore India Pharmaceutical announced that it developed and started manufacturing the key intermediates of Nirmatrelvir, one of the active ingredients of Paxlovid, the latest anti-Covid therapy

2021 saw greater collaboration among pharma, govt, academia: Sudarshan Jain

'Diversified supply chain is a fundamental need', said Jain

New-age pharmacy start-ups tap 'kirana' networks, eye US market

New entrants in the largely unorganised Indian pharmaceuticals market are trying out innovative ways to tap a vast market that lies in hinterland

Amid $126-mn target, Indian pharma exporters stare at Afghan uncertainty

As uncertainty looms large in Afghanistan, Indian pharma exporters are apprehensive to send goods to the war-torn country

Intense price competition in US generics market hits Indian pharma

Players say low prescription, double-digit price erosion are key reasons

Dr Reddy's to sell US, Canada territory rights for migraine drug to BDSI

Drug firm Dr Reddy's Laboratories on Wednesday said it has entered into a definitive agreement with BioDelivery Sciences International, Inc., to sell its US and Canada territory rights

Small contract manufacturers wait to take a shot at Covid vaccines

A host of lesser-known vaccine makers are eyeing contract manufacturing opportunities for global and domestic majors

Can produce 250 mn doses of Sputnik V every year: Morepen India CMD

The approval of samples, licensing, and final production will take around two months and the vaccine would be available in India for sale also in two months, says CMD Sushil Suri